Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0000950135-07-007562
Filing Date
2007-12-17
Accepted
2007-12-17 16:47:35
Documents
6
Effectiveness Date
2007-12-17

Document Format Files

Seq Description Document Type Size
1 ALNYLAM PHARMACEUTICALS, INC. b67751apsv8.htm S-8 43197
2 EX-5.1 - OPINION OF WILMER CUTLER PICKERING HALE AND DORR LLP b67751apexv5w1.htm EX-5.1 6856
3 EX-23.2 - CONSENT OF PRICEWATERHOUSECOOPERS LLP b67751apexv23w2.htm EX-23.2 1412
5 GRAPHIC b67751apb6775101.gif GRAPHIC 3063
6 GRAPHIC b67751apb6775102.gif GRAPHIC 3255
7 GRAPHIC b67751apb6775103.gif GRAPHIC 8304
  Complete submission text file 0000950135-07-007562.txt   73528
Mailing Address 300 THIRD STREET CAMBRIDGE MA 02142
Business Address 300 THIRD STREET CAMBRIDGE MA 02142 (617) 551-8200
ALNYLAM PHARMACEUTICALS, INC. (Filer) CIK: 0001178670 (see all company filings)

EIN.: 770602661 | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-148114 | Film No.: 071310522
SIC: 2834 Pharmaceutical Preparations